EGFR and cancer: Additionally, terms related to signaling axes that are commonly hijacked by cancer cells, such as terms related to ALK, TROP2, and TOB1, which is a growth-suppressive factor, and EGFR and ERBB (leading genes DAB2IP and PTPRJ) were enriched in both analyses.